Belgium · 
Who invested in Confo Therapeutics?
Confo Therapeutics's investors include Wellington Partners, Perceptive Advisors, BioGeneration Ventures, VIB and Qbic, and 11 more on record.
20172019202120232025
$2.8MGrant$34MSeries A$65MSeries B$1.2MGrant
Belgium · Funded startup
Who invested in Confo Therapeutics
Funding summaryUpdated 26 Oct 2026
$103Mraised across 4 rounds since 2017, from 6 sources
$2.8MGrant$34MSeries A$65MSeries B$1.2MGrant
- Latest round
- Grant, $1.2MOct 2025
- Biggest round
- $65MSeries B · Jul 2024
- Investors
- 16 (3 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $2.8M Feb 2017
- Biggest round
- $65M Series B · Jul 2024
- Usual gap between rounds
- 2.3 years the median of 3
The rounds
- Oct 2025Grant$1.2M2 new2 returning
Source recorded
- Jul 2024Series B$65M4 new9 returning
Ackermans & van HaarenLead
Perceptive Advisors
Wellington Partners
PMV
Quest for Growth
BioGeneration Ventures
VIB
Qbic- Fund+
V-Bio Ventures- Capricorn Health-Tech Fund
MINTS
Driehaus Capital Management
Reported by Capricorn Partners and 1 other
- May 2019Series A$34M10 new
- Wellington PartnersLead
- BioGeneration VenturesLead
- Perceptive Advisors
- VIB
- Qbic
- Fund+
- V-Bio Ventures
- Capricorn Health-Tech Fund
- MINTS
- Participatie Maatschappij Vlaanderen NV (PMV)
Reported by Capricorn Partners and 1 other
- Feb 2017
Founders and team
From Confo Therapeutics's own website: 6 on the team.
- Frank LandoltChief Counsel, Intellectual Property and Legal
- Joan Vermeiren. PhDHead of Development Project Management
- Leonie VangansbekeHead of Quality
- Marc De BoeckHead of IT
- Dieter WeinandChairman
- Rob ScottIndependent Director
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Grant2017Series A2019Series B2024Grant2025Wellington PartnersLPerceptive AdvisorsBioGeneration VenturesLVIBQbicFund+V-Bio VenturesCapricorn Health-Tech FundMINTSAckermans & van HaarenL
Wellington PartnersLPerceptive AdvisorsBioGeneration VenturesLVIBQbicFund+V-Bio VenturesCapricorn Health-Tech FundMINTSAckermans & van HaarenLEveryone who backed them
Fund+Company2rounds
Capricorn Health-Tech FundGrowth equity2rounds
Participatie Maatschappij Vlaanderen NV (PMV)VC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Confo Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Confo Therapeutics
How much has Confo Therapeutics raised?
Confo Therapeutics has raised $103M across 4 rounds since 2017.
When did Confo Therapeutics last raise?
Confo Therapeutics's most recent round was a Grant of $1.2M in Oct 2025.
What was Confo Therapeutics's biggest round?
Confo Therapeutics's largest round on record is $65M (Series B), in Jul 2024, led by Ackermans & van Haaren.
Who backed Confo Therapeutics first?
Confo Therapeutics's first round on record, in May 2019, was backed by Wellington Partners, BioGeneration Ventures and Perceptive Advisors and 7 others.
What stage is Confo Therapeutics at?
Confo Therapeutics's latest named round is a Grant, in Oct 2025.
Where is Confo Therapeutics based?
Confo Therapeutics is based in Belgium.
Who led Confo Therapeutics's rounds?
Wellington Partners led the Series A in 2019; Ackermans & van Haaren led the Series B in 2024.
Companies like Confo Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.